INS and diabetic ketoacidosis: Early recognition and timely immunosuppressive therapy are crucial for remission and prevention of metabolic complications.<h4>Case</h4>We report a 20-year-old Hispanic woman who presented with diabetic ketoacidosis (DKA), severe refractory hyperglycemia, and extreme insulin resistance requiring high doses of U-500 insulin.